| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2005 | CN1659170A Thienyl compounds |
| 08/24/2005 | CN1659169A Riboflavin derivative and its preparation method and uses |
| 08/24/2005 | CN1659168A Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/24/2005 | CN1659166A 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 08/24/2005 | CN1659165A Quinolinone derivatives |
| 08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659162A Tricyclic thrombin receptor antagonists |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659156A Novel guanidinobenzamides |
| 08/24/2005 | CN1659154A Method of preparing amine stereoisomers |
| 08/24/2005 | CN1659153A PNA monomer and precursor |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659150A Quinazoline derivative and medicine |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659146A Process for the manufacture of quinoline derivatives |
| 08/24/2005 | CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 08/24/2005 | CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1659137A N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1659133A 2, 5-bis-diamine-[1, 4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1659130A Induction of apoptosis in cancer cells |
| 08/24/2005 | CN1658940A Cell separation compositions and methods |
| 08/24/2005 | CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658890A Preparation extracted from stephania tetrandra S. Moor and the use thereof |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658887A Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658883A Methods for increasing the therapeutic response to electroconvulsive therapy |
| 08/24/2005 | CN1658882A Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas |
| 08/24/2005 | CN1658881A Anti-inflammatory compositions and methods of use |
| 08/24/2005 | CN1658880A Combination therapy for the treatment of cancer |
| 08/24/2005 | CN1658879A Neurotrophic factor production accelerator |
| 08/24/2005 | CN1658878A Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658876A A buffered, liquid nicotine composition for pulmonary administration |
| 08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658872A Antiallergic |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658870A Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658868A Bazedoxifene treatment regimens |
| 08/24/2005 | CN1658867A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658864A Stabilized ascorbic acid derivatives |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658862A Process for producing granules containing branched amino acids |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658860A Method of inhibiting angiogenesis |
| 08/24/2005 | CN1658859A Therapeutic agent for overactive bladder |
| 08/24/2005 | CN1658858A Remedies for neurodegenerative diseases |
| 08/24/2005 | CN1658857A NF-kB activation inhibitors |
| 08/24/2005 | CN1658856A Therapeutic agent for cancer |
| 08/24/2005 | CN1658854A Immunity-related protein kinase inhibitors |
| 08/24/2005 | CN1658853A Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX 2) inhibitor(s) |
| 08/24/2005 | CN1658852A Amidine derivatives for treating amyloidosis |
| 08/24/2005 | CN1658851A Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 08/24/2005 | CN1658850A Therapeutic drug for diabetes |
| 08/24/2005 | CN1658849A Inhibitors against the activation of AP-1 and NFAT |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1658846A 贴剂 Patch |
| 08/24/2005 | CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s) |
| 08/24/2005 | CN1658844A Low dose liquid entecavir formulations and use |
| 08/24/2005 | CN1658842A Novel polymorphs and pseudopolymorphs of risedronate sodium |
| 08/24/2005 | CN1658841A Cosmetic composition structured with silicone polymers and film-forming resins |
| 08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 08/24/2005 | CN1658839A Dry powder compositions |
| 08/24/2005 | CN1658837A Dry powder inhalant composition |
| 08/24/2005 | CN1658836A Processes for forming a drug delivery device |
| 08/24/2005 | CN1658834A Method of treating mucus hypersecretion |
| 08/24/2005 | CN1658833A Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 08/24/2005 | CN1658828A Gallocatechin gallate-containing composition |
| 08/24/2005 | CN1658766A Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive |
| 08/24/2005 | CN1658759A Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems |
| 08/24/2005 | CN1658757A Antihelminthic anthraquinones and method of use thereof |
| 08/24/2005 | CN1657618A Hepatic correlative oncogene inhibitory and use |
| 08/24/2005 | CN1657617A Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes |
| 08/24/2005 | CN1657537A Central body located gene and its use in medicinal region |
| 08/24/2005 | CN1657535A Rutin ester compounds |
| 08/24/2005 | CN1657534A Penthorum seponin (PCPTS) and its antihepatitis and antimutation aetion |
| 08/24/2005 | CN1657529A 2-substituted imine thia zlidine derivative its preparation technology and medicinal composition |
| 08/24/2005 | CN1657521A Bibenzyl compound plagiochin E and its extraction separation method and application |
| 08/24/2005 | CN1657100A Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 08/24/2005 | CN1657071A Asarum brain injection and its preparation method |